缅北禁地

Skip to main content

Staff Profile

Professor Alastair Greystoke

Professor of Precision Oncology

  • Telephone: +44 (0) 191 213 8476
  • Address: Sir Bobby Robson Clinical Trials Unit
    Freeman Hospital
    缅北禁地 upon Tyne
    NE7 7DN
Background

Professor Greystoke joined 缅北禁地 and the Northern Centre for Cancer Care in 2014 after 8 years spent at the University of Manchester/ Christie NHS Trust.  He is one of 4 consultants that run the Sir Bobby Robson Early Clinical Trials Centre at the Freeman hospital in 缅北禁地,and has a special interest in the development of new anti-cancer drugs for patients with lung cancer. He leads systemic therapy research for NSCLC in the North-East, with a portfolio of Phase I-IV studies. In addition he is the Clinical Director for Cancer for the Yorkshire, Hull and North East England Genomic Medicine Service and led the NHSE pilot assessing the cost-effectiveness of cfDNA in patients presenting with advanced lung cancer. He is the Joint Chief Investigator of the CONCORDE platform (adding in new drugs to radical radiotherapy in lung cancer), and leads the Pharmacodynamic Biomarker team at 缅北禁地 Cancer


Areas of expertise

  • Lung Cancer
  • Early Drug development
  • Personalised Medicine
  • Circulating Biomarkers
  • Treatment of cancer in the elderly


Google Scholar:

Publications

  • Articles

    • Norris RP, Fuller E, Greystoke A, Todd A, Sharp L. . Cancers 2025, 17(11), 1874.
    • Hochmair M, Schenker M, Cobo Dols M, Kim TM, Ozyilkan O, Smagina M, Leonova V, Kato T, Fedenko A, De Angelis F, Rittmeyer A, Gray JE, Greystoke A, Aggarwal H, Huang Q, Zhao B, Lara-Guerra H, Nadal E. . Journal of Thoracic Oncology 2025, 20(2), 203-218.
    • Lee SM, Hewish M, Ahmed S, Papadatos-Pastos D, Karapanagiotou E, Blackhall F, Ford A, Young R, Garcia A, Arora A, Hollingdale A, Ahmad T, Forster M, Greystoke A, Bremner F, Rudd R, Farrelly L, Vaja S, Hackshaw A. . European Journal of Cancer 2025, 215, 115162.
    • Crowe L, Brown MC, Lecouturier J, Greystoke A, Nuryunarsih D, Rimmer B, Bojke A, Bojke R, Richardson J, Wells M, Ezeala E, Carter L, Todd A, Sharp L. . Journal of Cancer Survivorship 2025, epub ahead of print.
    • Elliott K, Haworth E, Bolnykh I, McAllister-Williams HR, Greystoke A, Todd A, Sharp L. . The Breast 2025, 79, 103855.
    • Gulati P, Carruthers V, Hutton C, Cassidy C, Amankwatia EB, Pascual S, Florence E, Gebru TG, Jorgensen AL, Greystoke A, Makin G, McCabe MG, Hawcutt DB, Veal GJ, Jamieson D. . EJC Paediatric Oncology 2025, 5, 100216.
    • Norris RP, Dew R, Greystoke A, Cresti N, Cain H, Todd A, Sharp L. . CANCER EPIDEMIOLOGY, BIOMARKERS & PREVENTION 2024, 33(10), 1298-1310.
    • Rae S, Shaya S, Taylor E, Hoben J, Oluwashegun D, Lowe H, Haris N, Bashir S, Oing C, Krebs MG, Thistlethwaite FC, Carter L, Cook N, Greystoke A, Graham DM, Plummer R. . British Journal of Cancer 2024, 131, 685-691.
    • Bashir B, Wang JS, Falchook G, Fontana E, Arkenau H-T, Carter L, Galot R, Basu B, Greystoke A, Subbiah V, Richardson DL, Orr H, Bennett G, Sharma R, Xu H, Paganoni P, Xu C, Campbell C, McKean M. . Journal of Clinical Oncology 2024, 42(29), 3443-3452.
    • Gault A, Hogarth L, Williams KC, Greystoke A, Rajan N, Speight A, Lamb CA, Bridgewood A, Brown-Schofield LJ, Rayner F, Isaacs JD, Nsengimana J, Stewart CJ, Anderson AE, Plummer R, Pratt AG. . BMC Cancer 2024, 24(1), 733.
    • Wheatley DA, Berardi R, Climent Duran MA, Tomiak A, Greystoke AP, Joshua AM, Arkenau H-T, Geczi L, Corbacho JG, Paz-Ares LG, Hussain SA, Petruzelka L, Delmonte A, Chappey C, Masters JC, Michelon E, Murphy DA, Mwewa S, Cesari R, Doger de Speville B. . Cancer Research Communications 2024, 4(6), 1609-1619.
    • Messina C, Giunta EF, Signori A, Rebuzzi SE, Banna GL, Maniam A, Buti S, Cattrini C, Fornarini G, Bauckneht M, Greystoke A, Plummer R, Oing C, Rescigno P. . European Urology Oncology 2024, 7(2), 179-188.
    • Juric D, Barve M, Vaishampayan U, Roda D, Calvo A, Janez NM, Trigo J, Greystoke A, Harvey RD, Olszanski AJ, Opyrchal M, Spira A, Thistlethwaite F, Jimenez B, Sappal JH, Kannan K, Riley J, Li C, Li C, Gregory RC, Miao H, Wang S. . Cancer Medicine 2024, 13(5).
    • Crowe L, Brown M, Lecouturier J, Greystoke A, Bojke A, Bojke R, Richardson J, Wells M, Ezeala E, Carter L, Sharp L, Todd A. . European Journal of Oncology Nursing 2024, 73, 102696.
    • Norris RP, Dew R, Greystoke A, Todd A, Sharp L. . Journal of Thoracic Oncology 2023, 18(8), 990-1002.
    • Rae S, Plummer E, Fitzgerald L, Hogarth L, Bridgewood A, Brown-Schofield L, Graham J, Haigh S, McAnulty C, Drew Y, Haris N, Bashir S, Plummer R, Greystoke A. . Journal of Cancer Research and Clinical Oncology 2023, 149, 16355–16363.
    • Crowe L, Brown M, Bojke A, Bojke R, Greystoke A, Lecouturier J, Richardson J, Wells M, Todd A, Sharp L. . BMJ Open 2023, 13, e066229.
    • Halford S, Veal GJ, Wedge SR, Payne GS, Bacon CM, Sloan P, Dragoni I, Heinzmann K, Potter S, Salisbury BM, Chenard-Poirier M, Greystoke A, Howell EC, Innes WA, Morris K, Plummer C, Rata M, Petrides G, Keun HC, Banerji U, Plummer R. . Clinical Cancer Research 2023, 29(8), 1429-1439.
    • Welford J, Rafferty R, Hunt K, Short D, Duncan L, Ward A, Rushton C, Todd A, Nair S, Hoather T, Clarke M, Dawes L, Dawson F, Anderson V, Pelham A, Lowe H, Dewhurst F, Greystoke A. . European Journal of Cancer Care 2022, 31(6), e13752.
    • Zucali PA, Lin C-C, Carthon BC, Bauer TM, Tucci M, Italiano A, Iacovelli R, Su W-C, Massard C, Saleh M, Daniele G, Greystoke A, Gutierrez M, Pant S, Shen Y-C, Perrino M, Meng R, Abbadessa G, Lee H, Dong Y, Chiron M, Wang R, Loumagne L, Lepine L, de Bono J. . Journal for immunoTherapy of cancer 2022, 10(1), e003697.
    • Walker K, Hinsley S, Phillip R, Oughton JB, Murden G, Chalmers AJ, Faivre-Finn C, Greystoke A, Brown SR, Forster M, Franks K, Gilbert A, Hanna GG, Hannaway N, Harrow S, Haswell T, Hiley C, Krebs M, Salem A, Sebag-Montefiore D, Shaw P, Twelves C, Walls G, Young R. . JCO Precision Oncology 2022, 6, e2200133.
    • Cooper M, Chmelo J, Sinclair RCF, Charman S, Hallsworth K, Welford J, Phillips AW, Greystoke A, Avery L. . BMJ Open 2022, 12(9), e062526.
    • Chmelo J, Phillips AW, Greystoke A, Charman SJ, Avery L, Hallsworth K, Welford J, Cooper M, Sinclair RCF. . Pilot and Feasibility Studies 2022, 8(1), 173.
    • Harvie M, Pegington M, Howell SJ, Bundred N, Foden P, Adams J, Graves L, Greystoke A, Mattson MP, Cutler RG, Williamson J, Livingstone K, McMullen D, Sellers K, Lombardelli C, Cooper G, McDiarmid S, Howell A. . British Journal of Cancer 2021.
    • Chmelo J, Phillips AW, Greystoke A, Bradshaw A, Sinclair RCF. . British Journal of Surgery 2021, 108(10), e328-e329.
    • Middleton G, Fletcher P, Popat S, Savage J, Summers Y, Greystoke A, Gilligan D, Cave J, O'Rourke N, Brewster A, Toy E, Spicer J, Jain P, Dangoor A, MacKean M, Forster M, Farley A, Wherton D, Mehmi M, Sharpe R, Mills TC, Cerone MA, Yap TA, Watkins TBK, Lim E, Swanton C, Billingham L. . Nature 2020, 583, 807-812.
    • Gomes F, Lewis A, Morris R, Parks R, Kalsi T, Babic-Illamn G, Baxter M, Colquhoun K, Rodgers L, Smith E, Greystoke A, Bayman N, Cree A, Ng C, DE Liguori Carino N, Basile S, Moore J, Merchant Z, Swinson D, Parbhoo A, Jones R, Davies E, Danson SJ, Young R, Morgan J, Wyld L, Corrie PG, Doherty GJ, Crawford K, Wright J, Reed M, Ugolini F, Lind M, Cheung K-L, Harari D, Simcock R. . ecancermedicalscience 2020, 14, 1101.
    • Walls GM, Oughton JB, Chalmers AJ, Brown S, Collinson F, Forster MD, Franks KN, Gilbert A, Hanna GG, Hannaway N, Harrow S, Haswell T, Hiley CT, Hinsley S, Krebs M, Murden G, Phillip R, Ryan AJ, Salem A, Sebag-Montefoire D, Shaw P, Twelves CJ, Walker K, Young RJ, Faivre-Finn C, Greystoke A. . Clinical and Translational Radiation Oncology 2020, 25, 61-66.
    • Norris R, Dew R, Sharp L, Greystoke A, Rice S, Johnell K, Todd A. . BMC Medicine 2020, 18, 282.
    • Chmelo J, Phillips AW, Greystoke A, Charman SJ, Avery L, Hallsworth K, Welford J, Sinclair RCF. . Pilot and Feasibility Studies 2020, 6(1), 50.
    • Evans TRJ, Dean E, Molife LR, Lopez J, Ranson M, El-Khouly F, Zubairi I, Savulsky C, Reyderman L, Jia Y, Sweeting L, Greystoke A, Barriuso J, Kristeleit R. . British Journal of Cancer 2019, 120(4), 379–386.
    • Iqbal MS, Atherton P, Macgregor C, Wieczorek A, Singer J, Walther J, Little F, Harden S, Peedell C, Cyriac A, Chowdhury S, Bayne M, Yip K, Britten A, Powell C, Brock J, Datta S, Sevitt T, Mehta A, Greystoke A. . Annals of Oncology 2019, 30(2), ii36-ii36.
    • Coomer AO, Black F, Greystoke A, Munkley J, Elliott DJ. . Biochimica et Biophysica Acta - Gene Regulatory Mechanisms 2019, 1862(11-12), 194388.
    • Mak G, Soria J-C, Blagden SP, Plummer R, Fleming RA, Nebot N, Zhang J, Mazumdar J, Rogan D, Gazzah A, Rizzuto I, Greystoke A, Yan L, Tolson J, Auger KR, Arkenau H-T. . British Journal of Cancer 2019, 120, 975-981.
    • Gomes F, Tokaca N, Yip K, Ghosh S, Newsom-Davis T, Greystoke A, Mills H, Ahmed S, Harle AS, Ayre G, Shah R, Popat S, Blackhall FH, Summers Y. . Annals of Oncology 2019, 30(Supplement 2), ii53.
    • Ahn M-J, Chiu C-H, Cheng Y, Han J-Y, Goldberg SB, Greystoke A, Crawford J, Zhao Y, Huang X, Johnson M, Vishwanathan K, Mendoza-Naranjo A, Mok TSK. . Annals of Oncology 2019, 30(Supplement 2), ii48.
    • Perthen JE, Ali T, McCulloch D, Navidi M, Phillips AW, Sinclair RCF, Griffin SM, Greystoke A, Petrides G. . European Journal of Radiology 2018, 109, 142-146.
    • Navidi M, Phillips AW, Griffin SM, Duffield KE, Greystoke A, Sumpter K, Sinclair RCF. . British Journal of Surgery 2018, 105(7), 900-906.
    • Greystoke A, Steele N, Arkenau H-T, Blackhall F, Md Haris N, Lindsay CR, Califano R, Voskoboynik M, Summers Y, So K, Ghiorghiu D, Dymond AW, Hossack S, Plummer R, Dean E. . British Journal of Cancer 2017, 117(7), 938-946.
    • Cho BC, Kim D-W, Bearz A, Laurie SA, McKeage M, Borra G, Park K, Kim S-W, Ghosn M, Ardizzoni A, Maiello E, Greystoke A, Yu R, Osborne K, Gu W, Scott JW, Passos VQ, Lau YY, Wrona A. . Journal of Thoracic Oncology 2017, 12(9), 1357-1367.
    • Greystoke A, Ayub M, Rothwell DG, Morris D, Burt D, Hodgkinson CL, Morrow CJ, Smith N, Aung K, Valle J, Carter L, Blackhall F, Dive C, Brady G. . Molecular Oncology 2016, 10(2), 282-291.
    • Jamieson D, Griffin MJ, Sludden J, Drew Y, Cresti N, Swales K, Merriman M, Allen R, Bevan P, Buerkle M, Mala C, Coyle V, Rodgers L, Dean E, Greystoke A, Banerji U, Wilson RH, Evans TRJ, Anthoney A, Ranson M, Boddy AV, Plummer R. . European Journal of Cancer 2016, 68, 1-10.
    • Iqbal MS, Paleri V, Brown J, Greystoke A, Dobrowsky W, Kelly C, Kovarik J. . ecancermedicalscience 2015, 9, 594.
    • Basu B, Dean E, Pugilisi M, Greystoke A, Ong M, Burke W, Harrington L, Green S, Olemann E, DeBono JS, Ranson M, Banerji U. . Clinical Cancer Research 2015, 21(15), 3412-3419.
    • Greystoke A, Ayub M, Rothwell D, Morris D, Smith N, Carter L, Metcalf R, Blackhall F, Dive C, Brady G. Development of a Circulating miRNA Assay to Monitor Tumour Burden: from Mouse to Man. Cancer Research 2015. Submitted.
    • Hodgkinson CL, Morrow CJ, Li Y, Metcalf RL, Rothwell DG, Trapani F, Polanski R, Burt DJ, Simpson KL, Morris K, Pepper SD, Nonaka D, Greystoke A, Kelly P, Bola B, Krebs MG, Antonello J, Ayub M, Faulkner S, Priest L, Carter L, Tate C, Miller CJ, Blackhall F, Brady G, Dive C. . Nature Medicine 2014, 20(8), 897-903.
    • Molife LR, Dean E, BlancoCodesido M, Krebs MG, Brunetto A, Greystoke AP, Daniele G, Lee L, Kuznetsov G, Myint KT, deLasHeras B, Wood K, Ranson MR. . Clinical Cancer Research 2014, 20(24), 6284-6294.
    • Greystoke A, Harris G, Jenkins M, Goonetilleke D, Moore D, Lancashire M, Ranson M, Hughes A, Clack G, Dive C. . Journal of Pharmaceutical and Biomedical Analysis 2013, 84, 184-188.
    • Gibb A, Greystoke A, Ranson M, Linton K, Neeson S, Hampson G, Illidge T, Smith E, Dive C, Pettitt A, Lister A, Johnson P, Radford J. . British Journal of Cancer 2013, 109(10), 2560-2565.
    • Bouranis L, Sperrin M, Greystoke A, Dive C, Renehan AG. 0 0 1 10 57 NICR, 缅北禁地 1 1 66 14.0 96 800x600 Normal 0 false false false EN-GB JA X-NONE The interaction between prognostic and pharmaco-dynamic biomarkers. British Journal of Cancer 2013, 109(7), 1782-5. In Preparation.
    • Greystoke A, Dean E, Saunders MP, Cummings J, Hughes A, Ranson M, Dive C, Renehan AG. . British Journal of Cancer 2012, 107(9), 1518-1524.
    • Hou JM, Krebs MG, Lancashire L, Sloane R, Backen A, Swain RK, Priest LJ, Greystoke A, Zhou C, Morris K, Ward T, Blackhall FH, Dive C. . Journal of Clinical Oncology 2012, 30(5), 525-532.
    • Moore DJ, Greystoke A, Butt F, Wurther J, Growcott J, Hughes A, Dive C. . Clinical Drugs Investigation 2012, 32(3), 179-187.
    • Krebs MG, Sloane R, Priest L, Lancashire L, Hou JM, Greystoke A, Ferraldeschi R, Hughes A, Clack G, Dive C, Blackhall FH. 0 0 1 22 130 NICR, 缅北禁地 1 1 151 14.0 96 800x600 Normal 0 false false false EN-GB JA X-NONE Evaluation and prognostic significance of circulating tumour cells in patients with non small cell lung cancer (NSCLC). Journal of Clinical Oncology 2011, 29(12), 1556-63.
    • Khan OA, Gore M, Lorigan P, Stone J, Greystoke A, Burke W, Carmichael J, Watson AJ, McGown G, Thorncroft M, Margison GP, Califano R, Larkin J, Wellman S, Middleton MR. 0 0 1 20 118 NICR, 缅北禁地 1 1 137 14.0 96 800x600 Normal 0 false false false EN-GB JA X-NONE A phase I study of the safety and tolerability of olaparib (AZD2281, KU0059436) and dacarbazine in patients with advanced solid tumours. British Journal of Cancer 2011, 104(5), 750-5.
    • Greystoke A, OConnor JPB, Linton K, Taylor MB, Cummings J, Ward T, Hughes A, Maders F, Ranson M, Radford JA, Dive C. 0 0 1 15 88 NICR, 缅北禁地 1 1 102 14.0 96 800x600 Normal 0 false false false EN-GB JA X-NONE Assessment of circulating biomarkers for potential pharmacodynamic utility in patients with lymphoma. British Journal of Cancer 2011, 104(4), 719-25. In Preparation.
    • Brookes K, Cummings J, Backen A, Greystoke A, Ward T, Jayson GC, Dive C. Issues on fit-for-purpose validation of a panel of ELISAs for application as biomarkers in clinical trials of anti-Angiogenic drugs. British Journal of Cancer 2010, 102(10), 1524-32.
    • Greystoke A, Jodrell DI, Cheung M, Rivans I, Mackean MJ. How many cisplatin administration protocols does your department use?. European Journal of Cancer Care 2010, 19(1), 80-90.
    • Board RE, Wardley AM, Dixon JM, Armstrong AC, Howell S, Renshaw L, Donald E, Greystoke A, Ranson M, Hughes A, Dive C. Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer. Breast Cancer Research and Treatment 2010, 120(2), 461-7.
    • Hou JM, Greystoke A, Lancashire L, Cummings J, Ward T, Board R, Amir E, Hughes S, Krebs M, Hughes A, Ranson M, Lorigan P, Dive C, Blackhall FH. Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapy. 175 2009, 2, 808-16.
    • Greystoke A, Cummings J, Ward T, Simpson K, Renehan A, Butt F, Moore D, Gietema J, Blackhall F, Ranson M, Hughes A, Dive C. Optimisation of circulating biomarkers of cell death for routine clinical use. Annals of Oncology 2008, 19(5), 990-5. In Preparation.
    • Board RE, Williams VS, Knight L, Shaw J, Greystoke A, Ranson M, Dive C, Blackhall FH, Hughes A. Isolation and extraction of circulating tumor DNA from patients with small cell lung cancer. Annals of New York Academy of Science 2008, 1137, 98.
    • Greystoke A, Blagden S, Thomas AL, Scott E, Attard G, Molife R, Vidal L, Pacey S, Sarkar D, Jenner A, DeBono JS, Steward W. A phase I study of intravenous TZT-1027 administered on day 1 and day 8 of athree-weekly cycle in combination with carboplatin given on day 1 alone inpatients with advanced solid tumours. Annals of Oncology 2006, 17(8), 1313-9.

  • Conference Proceedings (inc. Abstracts)

    • Norris RP, Dew R, Greystoke A, Todd A, Sharp L. . In: Society for Social Medicine & Population Health 67th Annual Scientific meeting. 2023, Journal of Epidemiology and Community Health.
    • Norris RP, Fuller E, Greystoke A, Todd A, Sharp L. . In: Society for Social Medicine & Population Health 67th Annual Scientific meeting. 2023, 缅北禁地 upon Tyne: BMJ.
    • Norris RP, Dew R, Todd A, Greystoke A, Sharp L. . In: 2022 World Conference on Lung Cancer. 2022, Vienna, Austria: Elsevier.
    • Greystoke A, Hogarth L, Patterson M, Williams I, Ness T, Georgiadis K, Bolt L, Bettison I, Turner D, Jamieson D, Simmons T, Hughes A, Jaedicke K, Gardiner J, Mulvenna P, Leaning D, Bradshaw A, Butler R, Black F. . In: 14th Annual British Thoracic Oncology Group Conference 2016. 2016, Dublin, Ireland: Elsevier.
    • Dean E, Steele N, Arkenau HT, Blackhall F, Haris NM, Lindsay C, Rafii S, Califano R, Plummer R, Voskoboynik M, Summers YJ, Ghiorghiu D, Dymond A, So K, Greystoke A. . In: 41st ESMO Congress (ESMO 2016). 2016, Copenhagen, Denmark: Oxford University Press.
    • Hall S, Lambourne B, Aynsley E, Gardiner J, Greystoke A, Hughes A, Jones C, Leaning D, Li L, Mansy T, Margetts J, Mcdonald F, Mcmenemin R, Mulvenna P, Peedell C, Shakespeare D, Simmons T, Singhal S, Turnbull H. . In: 14th Annual British Thoracic Oncology Group Conference 2016. 2016, Dublin, Ireland: Elsevier Ireland Ltd.
    • Wyatt N, Hogarth L, Turner D, Patterson M, Jamieson D, Black F, Hutton C, Mulvenna P, Simmons T, Bradshaw A, Kolenda C, Parker C, Martin-Ruiz C, Greystoke A. . In: IASLC 17th World Conference on Lung Cancer. 2016, Vienna, Austria: Elsevier.
    • Arkenau HT, Gazzah A, Plummer R, Blagden SP, Mak G, Soria JC, Greystoke A, Rizzuto I, Rogan D, Mazumdar J, Laubscher K, Auger KR, Swartz LS, Mattern ML, Nebot N, Singh RP, Fleming RA, Yan L. . In: American Society of Clinical Oncology (ASCO) 2015 Annual Meeting. 2015, Chicago, Illinois, USA: American Society of Clinical Oncology.
    • Roda D, Drew Y, Azaro A, Smith AD, Greystoke A, Sicart E, Escriba PV, Busquets X, Llado V, Tur V, Klumper E, Ahnert JR, Molife LR, Plummer R. . In: 2015 American Society of Clinical Oncology Annual Meeting. 2015, Chicago, Illinois, USA: American Society of Clinical Oncology.
    • Vidal L, Leslie M, Sludden J, Griffin MG, Plummer R, Judson I, Lee C, Greystoke A, Calvert AH, Boddy AV. . In: 42nd Meeting of the American Society of Clinical Oncology Annual Meeting Proceedings. 2005, Orlando, Florida, USA: Journal of Clinical Oncology, American Society of Clinical Oncology.

  • Editorials

    • Greystoke A, Chaturvedi A. . Drug Discovery Today 2015, 20(12), 1409-1413.
    • Greystoke A, Ranson M. . Annals of Oncology 2012, 23(8), 1934-1936.

  • Reviews

    • Gomes F, Farrington N, Pearce J, Swinson D, Welford J, Greystoke A, Baxter M, Brown-Kerr AG, Wyld L, Morgan J, Battisti NML, Barrell A, Cobben D, Cree A, Johnston M, Colquhoun K, Phillips I, Smith J, Stapley S, Lyons L, Balachandran K, Brown H, Bryce R, Dacie R, Parks R, Denholm M, Harari D, Rigden T, Sommer D, Williams K, Worby K, Cheung K-L. . Journal of Geriatric Oncology 2025, 16(1), 102133.
    • Decoster L, Camidge DR, Fletcher JA, Addeo A, Greystoke A, Kantilal K, Game LB, Kanesvaran R, Gomes F. . Lung Cancer 2025, 200, 108087.
    • Aldea M, Rotow JK, Arcila M, Hatton M, Sholl L, Rolfo C, Tagliamento M, Radonic T, Schalper KA, Subbiah V, Malapelle U, Roden AC, Manochakian R, Tsao M-S, Linardou H, Hui R, Novello S, Greystoke A, Saqi A, Lantuejoul S, Hwang DM, Nevins K, Wynes M, Waqar S, Han Y, Yatabe Y, Chang W-C, Hayashi T, Kim T-J, Hofman P, Tavora F, Hirsch FR, Denninghoff V, Leighl NB, Drilon A, Cooper WA, Dacic S, Mohindra P, Pavlakis N, Lopez-Rios F. . Journal of Thoracic Oncology 2025, 20(11), 1594-1614.
    • D'Arcangelo M, Margetts J, Greystoke A. The use of circulating biomarkers in early clinical trials in patients with cancer. Biomarkers in Medicine 2015, 9(10), 1011-1023.
    • Greystoke A, Mullamitha SA. . Gastroenterology Research and Practice 2012, 2012, 564741.
    • Dean E, Greystoke A, Ranson M, Dive C. . Experimental Cell Research 2012, 318(11), 1252-1259.